227 related articles for article (PubMed ID: 20716639)
1. Urokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cells.
Chetty C; Lakka SS; Bhoopathi P; Gondi CS; Veeravalli KK; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
Mol Cancer Ther; 2010 Sep; 9(9):2605-17. PubMed ID: 20716639
[TBL] [Abstract][Full Text] [Related]
2. siRNA-mediated downregulation of MMP-9 and uPAR in combination with radiation induces G2/M cell-cycle arrest in Medulloblastoma.
Nagaraju GP; Nalla AK; Gupta R; Mohanam S; Gujrati M; Dinh DH; Rao JS
Mol Cancer Res; 2011 Jan; 9(1):51-66. PubMed ID: 21148633
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.
Gondi CS; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2008 Oct; 33(4):783-90. PubMed ID: 18813792
[TBL] [Abstract][Full Text] [Related]
4. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
[TBL] [Abstract][Full Text] [Related]
5. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.
Nalla AK; Gorantla B; Gondi CS; Lakka SS; Rao JS
Cancer Gene Ther; 2010 Sep; 17(9):599-613. PubMed ID: 20448670
[TBL] [Abstract][Full Text] [Related]
6. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
[TBL] [Abstract][Full Text] [Related]
7. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
Kunigal S; Lakka SS; Gondi CS; Estes N; Rao JS
Int J Cancer; 2007 Nov; 121(10):2307-16. PubMed ID: 17657740
[TBL] [Abstract][Full Text] [Related]
8. Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration.
Zhuang T; Chelluboina B; Ponnala S; Velpula KK; Rehman AA; Chetty C; Zakharian E; Rao JS; Veeravalli KK
BMC Cancer; 2013 Dec; 13():590. PubMed ID: 24325546
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis induced by knockdown of uPAR and MMP-9 is mediated by inactivation of EGFR/STAT3 signaling in medulloblastoma.
Kotipatruni RR; Nalla AK; Asuthkar S; Gondi CS; Dinh DH; Rao JS
PLoS One; 2012; 7(9):e44798. PubMed ID: 22984561
[TBL] [Abstract][Full Text] [Related]
10. Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells.
Raghu H; Sodadasu PK; Malla RR; Gondi CS; Estes N; Rao JS
BMC Cancer; 2010 Nov; 10():647. PubMed ID: 21106094
[TBL] [Abstract][Full Text] [Related]
11. Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy.
Gajate C; Mollinedo F
J Biol Chem; 2005 Mar; 280(12):11641-7. PubMed ID: 15659383
[TBL] [Abstract][Full Text] [Related]
12. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
[TBL] [Abstract][Full Text] [Related]
13. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
Kiyan J; Smith G; Haller H; Dumler I
Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway.
Gondi CS; Kandhukuri N; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2007 Jul; 31(1):19-27. PubMed ID: 17549401
[TBL] [Abstract][Full Text] [Related]
16. Integrin α9β1-mediated cell migration in glioblastoma via SSAT and Kir4.2 potassium channel pathway.
Veeravalli KK; Ponnala S; Chetty C; Tsung AJ; Gujrati M; Rao JS
Cell Signal; 2012 Jan; 24(1):272-81. PubMed ID: 21946432
[TBL] [Abstract][Full Text] [Related]
17. MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.
Veeravalli KK; Chetty C; Ponnala S; Gondi CS; Lakka SS; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
PLoS One; 2010 Jul; 5(7):e11583. PubMed ID: 20657647
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas.
Malla R; Gopinath S; Alapati K; Gondi CS; Gujrati M; Dinh DH; Mohanam S; Rao JS
PLoS One; 2010 Oct; 5(10):e13731. PubMed ID: 21060833
[TBL] [Abstract][Full Text] [Related]
19. Avicin D, a plant triterpenoid, induces cell apoptosis by recruitment of Fas and downstream signaling molecules into lipid rafts.
Xu ZX; Ding T; Haridas V; Connolly F; Gutterman JU
PLoS One; 2009 Dec; 4(12):e8532. PubMed ID: 20046832
[TBL] [Abstract][Full Text] [Related]
20. RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells.
Gondi CS; Kandhukuri N; Kondraganti S; Gujrati M; Olivero WC; Dinh DH; Rao JS
Mol Cancer Ther; 2006 Dec; 5(12):3197-208. PubMed ID: 17172424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
